Conditions: Cataract
Keywords: Cataract
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 184
Healthy volunteers: no

Brief summary:
The objective of the study is to assess how DisCoVisc Ophthalmic Viscosurgical Device (OVD) compares with Healon and Amvisc Plus in the protection of corneal endothelial cells, and the ability to maintain anterior chamber space, in routine cataract surgery.

Detailed description:

Arms:
arm 1: DisCoVisc® Ophthalmic Viscosurgical Device arm 2: Healon arm 3: Amvisc Plus

Interventions: intervention 1: DisCoVisc® intervention 2: Healon intervention 3: Amvisc Plus
Intervention descriptions: intervention 1: Injection of DisCoVisc® Ophthalmic Viscosurgical Device (OVD) into the anterior chamber prior to and throughout the cataract surgery procedure intervention 2: Injection of Healon into the anterior chamber prior to and throughout the cataract surgery procedure intervention 3: Injection of Amvisc Plus into the anterior chamber prior to and throughout the cataract surgery procedure

Protocol document: